Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Case report

Peritoneal dialysis-associated infection caused by Mycobacterium abscessus: a case report

Authors: Ryuichi Yoshimura, Miharu Kawanishi, Shungo Fujii, Aska Yamauchi, Kentaro Takase, Kaori Yoshikane, Masahiro Egawa, Hiroaki Shiina, Takafumi Ito

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Peritoneal dialysis (PD)-associated infection caused by Mycobacterium spp. is rare. Mycobacterium abscessus is one of the most resistant acid-fast bacteria, and treatment is also the most difficult and refractory. Thus, we report a case of PD-associated peritonitis caused by Mycobacterium abscessus that was difficult to treat and led to PD failure.

Case presentation

We recently encountered a 56-year-old man who developed PD-associated infection. We initially suspected exit-site infection (ESI) and tunnel infection (TI) caused by methicillin-resistant coagulase-negative Staphylococcus. However, antibiotic therapy did not provide any significant improvement. Thus, we performed simultaneous removal and reinsertion of a PD catheter at a new exit site. The patient subsequently developed peritonitis and Mycobacterium abscessus was detected in the peritoneal effluent. Thus, the reinserted catheter was removed, hemodialysis was started, and the patient was eventually discharged.

Conclusions

In cases of refractory ESI or TI, it is important to consider non-tuberculous mycobacteria as the potentially causative organism. Even if acid-fast bacterial staining is negative or not performed, detection of Gram-negative bacillus may lead to suspicion and early identification of Mycobacterium spp. In PD-associated infection by Mycobacterium abscessus, catheter removal is necessary in many cases. Simultaneous removal and reinsertion of the catheter is not recommended, even in cases of ESI or TI. Reinsertion should only be attempted after complete resolution of peritoneal symptoms. After removal of the catheter, careful follow-up is necessary, paying attention to complications such as wound infection, peritonitis, and ileus. In addition, the selection and treatment period of antibiotics in PD-associated infection by Mycobacterium abscessus remains unclear, and it is an important topic for future discussion.
Literature
1.
go back to reference Piraino B, Bernardini J, Sorkin M. The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1986;8:436–40.CrossRef Piraino B, Bernardini J, Sorkin M. The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1986;8:436–40.CrossRef
2.
go back to reference van Diepen AT, Tomlinson GA, Jassal SV. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients. Clin J Am Soc Nephrol. 2012;7:1266–71.CrossRef van Diepen AT, Tomlinson GA, Jassal SV. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients. Clin J Am Soc Nephrol. 2012;7:1266–71.CrossRef
3.
go back to reference Szeto CC, Leung CB, Chow KM. Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a Centre in South-East Asia. Clin Microbiol Infect. 2005;11:837–9.CrossRef Szeto CC, Leung CB, Chow KM. Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a Centre in South-East Asia. Clin Microbiol Infect. 2005;11:837–9.CrossRef
4.
go back to reference Song Y, Wu J, Yan H, Chen J. Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant. 2012;27:1639–44.CrossRef Song Y, Wu J, Yan H, Chen J. Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant. 2012;27:1639–44.CrossRef
5.
go back to reference Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36:481–508.CrossRef Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36:481–508.CrossRef
6.
go back to reference Renaud CJ, Subramanian S, Tambyah PA, Lee EJ. The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: a case series and literature review. Nephrology (Carlton). 2011;16:174–9.CrossRef Renaud CJ, Subramanian S, Tambyah PA, Lee EJ. The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: a case series and literature review. Nephrology (Carlton). 2011;16:174–9.CrossRef
7.
go back to reference Jiang SH, Roberts DM, Clayton PA, Jardine M. Non-tuberculous mycobacterial PD peritonitis in Australia. Int Urol Nephrol. 2013;45:1423–8.CrossRef Jiang SH, Roberts DM, Clayton PA, Jardine M. Non-tuberculous mycobacterial PD peritonitis in Australia. Int Urol Nephrol. 2013;45:1423–8.CrossRef
8.
go back to reference Kusunoki S, Ezaki T, Tamesada M. Application of colorimetric microdilution plate hybridization for rapid genetic identification of 22 Mycobacterium species. J Clin Microbiol. 1991;29:1596–603.PubMedPubMedCentral Kusunoki S, Ezaki T, Tamesada M. Application of colorimetric microdilution plate hybridization for rapid genetic identification of 22 Mycobacterium species. J Clin Microbiol. 1991;29:1596–603.PubMedPubMedCentral
9.
go back to reference Mooren VHJF, Bleeker MWP, van Ingen J, Hermans MHA, Wever PC. Disseminated Mycobacterium abscessus infection in a peritoneal dialysis patient. IDCases. 2017;9:6–7.CrossRef Mooren VHJF, Bleeker MWP, van Ingen J, Hermans MHA, Wever PC. Disseminated Mycobacterium abscessus infection in a peritoneal dialysis patient. IDCases. 2017;9:6–7.CrossRef
10.
go back to reference Hibi A, Kasugai T, Kamiya K. Peritoneal dialysis-associated catheter infection caused by Mycobacterium abscessus in an elderly patient who was successfully treated with catheter removal. CEN Case Rep. 2017;6:175–9.CrossRef Hibi A, Kasugai T, Kamiya K. Peritoneal dialysis-associated catheter infection caused by Mycobacterium abscessus in an elderly patient who was successfully treated with catheter removal. CEN Case Rep. 2017;6:175–9.CrossRef
11.
go back to reference Yang TK, Lee JJ, Lu PL, Kuo HT, Kuo MC, Chen HC. Peritoneal Dialysis-associated peritonitis caused by Mycobacterium abscessus. Perit Dial Int. 2015;35:369–71.CrossRef Yang TK, Lee JJ, Lu PL, Kuo HT, Kuo MC, Chen HC. Peritoneal Dialysis-associated peritonitis caused by Mycobacterium abscessus. Perit Dial Int. 2015;35:369–71.CrossRef
12.
go back to reference Tsai SF. Catheter related infection due to Mycobacterium abscessus in a patient under peritoneal dialysis. Ther Apher Dial. 2013;17:349–50.CrossRef Tsai SF. Catheter related infection due to Mycobacterium abscessus in a patient under peritoneal dialysis. Ther Apher Dial. 2013;17:349–50.CrossRef
13.
go back to reference Lo MW, Mak SK, Wong YY, et al. Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream. Perit Dial Int. 2013;33:267–72.CrossRef Lo MW, Mak SK, Wong YY, et al. Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream. Perit Dial Int. 2013;33:267–72.CrossRef
14.
go back to reference Jo A, Ishibashi Y, Hirohama D, Takara Y, Kume H, Fujita T. Early surgical intervention may prevent peritonitis in cases with Tenckhoff catheter infection by nontuberculous mycobacterium. Perit Dial Int. 2012;32:227–9.CrossRef Jo A, Ishibashi Y, Hirohama D, Takara Y, Kume H, Fujita T. Early surgical intervention may prevent peritonitis in cases with Tenckhoff catheter infection by nontuberculous mycobacterium. Perit Dial Int. 2012;32:227–9.CrossRef
15.
go back to reference Siddiqi N, Sheikh I. Peritonitis caused by Mycobacterium abscesses in patients on continuous ambulatory peritoneal dialysis. Saudi J Kidney Dis Transpl. 2012;23:321–4.PubMed Siddiqi N, Sheikh I. Peritonitis caused by Mycobacterium abscesses in patients on continuous ambulatory peritoneal dialysis. Saudi J Kidney Dis Transpl. 2012;23:321–4.PubMed
16.
go back to reference Kameyama H, Mori Y, Kimura T, et al. A case report of Mycobacterium abscessus peritonitis in a peritoneal dialysis patient. Ther Apher Dial. 2007;11:449–51.CrossRef Kameyama H, Mori Y, Kimura T, et al. A case report of Mycobacterium abscessus peritonitis in a peritoneal dialysis patient. Ther Apher Dial. 2007;11:449–51.CrossRef
17.
go back to reference Ellis EN, Schutze GE, Wheeler JG. Nontuberculous mycobacterial exit-site infection and abscess in a peritoneal dialysis patient. A case report and review of the literature. Pediatr Nephrol. 2005;20:1016–8.CrossRef Ellis EN, Schutze GE, Wheeler JG. Nontuberculous mycobacterial exit-site infection and abscess in a peritoneal dialysis patient. A case report and review of the literature. Pediatr Nephrol. 2005;20:1016–8.CrossRef
18.
go back to reference Slagle KM, Oblack DL. Mycobacterium abscessus peritonitis: a case report. Clin Lab Sci. 1998;11:206–8.PubMed Slagle KM, Oblack DL. Mycobacterium abscessus peritonitis: a case report. Clin Lab Sci. 1998;11:206–8.PubMed
19.
go back to reference Pierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Perit Dial Int. 2012;32:525–30.CrossRef Pierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Perit Dial Int. 2012;32:525–30.CrossRef
20.
go back to reference Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.CrossRef Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.CrossRef
21.
go back to reference Stone MS, Wallace RJ Jr, Swenson JM, Thornsberry C, Christensen LA. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics. Antimicrob Agents Chemother. 1983;24:486–93.CrossRef Stone MS, Wallace RJ Jr, Swenson JM, Thornsberry C, Christensen LA. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics. Antimicrob Agents Chemother. 1983;24:486–93.CrossRef
22.
go back to reference Swenson JM, Wallace RJ Jr, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 1985;28:807–11.CrossRef Swenson JM, Wallace RJ Jr, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 1985;28:807–11.CrossRef
23.
go back to reference Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ 3rd. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992;36:180–184. Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ 3rd. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992;36:180–184.
24.
go back to reference Wallace RJ Jr, Brown BA, Onyi GO. Susceptibilities of Mycobacterium fortuitum biovar. Fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother. 1991;35:773–5.CrossRef Wallace RJ Jr, Brown BA, Onyi GO. Susceptibilities of Mycobacterium fortuitum biovar. Fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother. 1991;35:773–5.CrossRef
25.
go back to reference Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis. 1985;152:500–14.CrossRef Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis. 1985;152:500–14.CrossRef
Metadata
Title
Peritoneal dialysis-associated infection caused by Mycobacterium abscessus: a case report
Authors
Ryuichi Yoshimura
Miharu Kawanishi
Shungo Fujii
Aska Yamauchi
Kentaro Takase
Kaori Yoshikane
Masahiro Egawa
Hiroaki Shiina
Takafumi Ito
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-1148-2

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.